Application of Gadolinium-Based Contrast Agents and Prevalence of Nephrogenic Systemic Fibrosis in a Cohort of End-Stage Renal Disease Patients on Hemodialysis-Reference-Cited by-同舟云学术

Application of Gadolinium-Based Contrast Agents and Prevalence of Nephrogenic Systemic Fibrosis in a Cohort of End-Stage Renal Disease Patients on Hemodialysis

Published:2012 Issue:1-2 Volume:121 Page:c91-c94
ISSN:1660-2110
Container-title:Nephron Clinical Practice
language:en
Short-container-title:Nephron Clin Pract

Author:

Becker Stefan,Walter Stefan,Witzke Oliver,Kreuter Alexander,Kribben Andreas,Mitchell Anna

Publisher

S. Karger AG

Subject

Nephrology,General Medicine

Reference11 articles.

1. Nephrogenic Fibrosing Dermopathy

2. Nephrogenic Fibrosing Dermopathy With Systemic Involvement

3. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

4. Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium: Is There a Link?: Figure 1.

5. Gadolinium and Nephrogenic Systemic Fibrosis: Have We Overreacted?

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kontrastmittelgabe bei Niereninsuffizienz – praktische Handlungsempfehlungen;DMW - Deutsche Medizinische Wochenschrift;2021-11

2. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents;Annals of Internal Medicine;2020-07-21

3. Management of small renal masses in patients with chronic kidney disease: Perspectives from a nephrologist;Urologic Oncology: Seminars and Original Investigations;2020-05

4. A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis;Radiology;2019-08

5. Nierenfunktion bei kontrastmittelverstärkter Bildgebung;Der Radiologe;2019-04-23